Enliven to Present Clinical Data at SOHO 2026 Meeting
SAN FRANCISCO, California, Sept. 2, 2026 Enliven Therapeutics announced plans to present new clinical and preclinical data from its...
Ebola Virus Disease
Advertisement
UCB Agreement Targets Medicine Costs and U.S. Manufacturing
BRUSSELS, Belgium and ATLANTA, Georgia, Aug. 31, 2026 UCB has reached an agreement with the U.S. government aimed at...
TTX-MC138 Shows Survival Benefit in Breast Cancer
BOSTON, Aug. 31, 2026 TransCode Therapeutics announced the publication of new peer-reviewed research reporting a survival benefit for TTX-MC138...
RedHill Advances Opaganib for Ebola Outbreak Response
Raleigh, North Carolina, August 31, 2026 RedHill Biopharma Ltd. announced an update on the emergency development of opaganib as...
RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak
TEL AVIV, Israel and RALEIGH, N.C., June 2, 2026 RedHill Biopharma has announced efforts to advance the clinical development...
Advertisement
